Sunday, April 26, 2026

Latest
Canada’s Resource Minister Predicts Up to 10 Major Projects to Break Ground by Next Year
BC’s New Gas Royalty Regime Sparks Industry Concerns Ahead of January Launch
NDP Faces Further Decline as Boulerice Set to Exit for Québec Solidaire on Monday
US-EU Inks Critical Minerals Trade Plan As A Move To Break China Dependency
Netanyahu Reveals Early-Stage Prostate Cancer Treatment Amid Iran Conflict
The Fine Print In Trump’s Most-Favored-Nation Drug Price Deal With Regeneron
Bank of America Sees Silver Surging to $309 in Extreme Scenario as Supply Deficit Deepens
Justice Department Drops Criminal Probe of Fed Chair Powell, Clearing Path for Warsh Nomination
China Built the World’s Largest Oil Stockpile From Discounted Sanctioned Crude
The Grocery Grift: Why Toronto and New York Are About to Light Taxpayer Money on Fire
Search

Revive Therapeutics

Revive Therapeutics Announces Research Collaboration For Natural Psilocybin Biosynthesis
January 14, 2021, 08:52:49 AM
Read More

Revive Therapeutics Appoints Airway Disease Expert As Advisor For COVID-19 Phase 3 Study
December 31, 2020, 07:39:28 AM
Read More

Revive Therapeutics Continues With Phase 3 Clinical Trial For Bucillamine, To File For Emergency Use Authorization
December 23, 2020, 09:48:31 AM
Read More

Revive Therapeutics Enters LOI To Acquire Psilocybin Program From PharmaTher
December 21, 2020, 08:38:29 AM
Read More

Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics
December 4, 2020, 01:00:00 PM
Read More

Revive Therapeutics, Pharmather Partner On Psilocybin Cancer Research
November 18, 2020, 07:30:40 AM
Read More

Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product
November 11, 2020, 09:35:55 AM
Read More

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19
October 26, 2020, 10:54:38 AM
Read More

Havn Life to Supply Revive Therapeutics With Psychedelic Compounds
October 20, 2020, 10:16:16 AM
Read More

Revive Selects Clinical Sites for FDA Phase 3 Clinical Trials
September 29, 2020, 09:45:22 AM
Read More
Latest News
RBC $6,500 Gold Forecast Shows Miner Cash Flow Surge
BHP Shifts to Yuan-Based Index for Chinese Iron Ore Sales in Landmark Deal
US Mint Under Scrutiny for Sourcing Gold Tied to Drug Cartels
Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic
Agnico Eagle Just Made a Massive Gold Land Grab
A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold
Brazil Court Petitioned to Halt Serra Verde Sale to USA Rare Earth
Why Discipline Matters in a High Gold Price Market | Darren Hall – Equinox Gold
Poilievre’s Attack On Carney’s Brookfield Tax Haven Comes Back
Anti-MAGA Influencer Claims CBS Shelved His Debate After Bari Weiss
Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold
Recommended

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Kirkland Lake Drills 121 Metres Of 1.01 g/t Gold At Mirado
Trending
© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.